<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00653692</url>
  </required_header>
  <id_info>
    <org_study_id>9811</org_study_id>
    <secondary_id>R01DA019934</secondary_id>
    <secondary_id>DPMCDA</secondary_id>
    <nct_id>NCT00653692</nct_id>
  </id_info>
  <brief_title>Fetal Neurobehavior in Poly-drug Dependent Women</brief_title>
  <official_title>Methadone, Buprenorphine and Fetal Neurobehavior</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project examines fetal neurobehavior and maternal physiology in poly-drug dependent
      women. This study also evaluates infant neonatal abstinence syndrome, infant neurobehavior
      and vagal tone in the post-partum period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Little is known about the link between maternal physiology, fetal neurobehavior and neonatal
      abstinence syndrome in multiply drug-dependent women. Previous research by this group of
      investigators has found that the severity of neonatal abstinence syndrome in methadone
      exposed infants is related to maternal vagal tone changes in response to methadone during
      pregnancy. While previous research has focused on drug abstinent, methadone maintained women,
      most drug dependent pregnant women are poly-substance abusers who also use prescription
      psychiatric medications, alcohol and nicotine. This protocol seeks to further our
      understanding of the effects of multiple drugs on the fetus, including the co-variate effects
      of maternal psychological status. Infant neurobehavior and vagal tone will also be evaluated.
      This research will extend our knowledge of fetal neurobehavioral development and neonatal
      abstinence syndrome in a realistic population of poly-drug dependent women, potentially
      altering the way in which these women are evaluated and their infants monitored and treated
      for neonatal abstinence syndrome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fetal heart rate</measure>
    <time_frame>120 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fetal movement</measure>
    <time_frame>120 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>neonatal abstinence syndrome</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">29</enrollment>
  <condition>Poly Drug Exposed Pregnancies</condition>
  <arm_group>
    <arm_group_label>Observational</arm_group_label>
    <description>Poly drug dependent women</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Poly drug dependent pregnant women
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-41

          -  Single intrauterine fetus

          -  Free of significant maternal or fetal significant health complications

        Exclusion Criteria:

          -  Development of significant maternal or fetal health complications

          -  Significant maternal psychopathology that would preclude informed consent

          -  Unwilling or unable to receive methadone at prescribed times
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lauren M Jansson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Center for Addiction and Pregnancy</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Jansson LM, Di Pietro JA, Elko A, Williams EL, Milio L, Velez M. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes. Drug Alcohol Depend. 2012 May 1;122(3):213-9. doi: 10.1016/j.drugalcdep.2011.10.003. Epub 2011 Oct 29.</citation>
    <PMID>22041255</PMID>
  </results_reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2008</study_first_submitted>
  <study_first_submitted_qc>April 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2008</study_first_posted>
  <last_update_submitted>February 20, 2013</last_update_submitted>
  <last_update_submitted_qc>February 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Institute on Drug Abuse (NIDA)</investigator_affiliation>
    <investigator_full_name>Lauren M. Jansson</investigator_full_name>
    <investigator_title>Associate Professor of Pediatrics Johns Hopkins University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>Substance abuse</keyword>
  <keyword>fetal development</keyword>
  <keyword>vagal tone</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

